These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28189578)

  • 21. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The top tertile of hematocrit change during hospitalization is associated with lower risk of mortality in acute heart failure patients.
    Zhou H; Xu T; Huang Y; Zhan Q; Huang X; Zeng Q; Xu D
    BMC Cardiovasc Disord; 2017 Sep; 17(1):235. PubMed ID: 28865437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term and Short-Term Prognostic Value of Circulating Soluble Suppression of Tumorigenicity-2 Concentration in Chronic Heart Failure: A Systematic Review and Meta-Analysis.
    Dong G; Chen H; Zhang H; Gu Y
    Cardiology; 2021; 146(4):433-440. PubMed ID: 33902050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of serum chloride concentrations in acute heart failure patients: A systematic Rreview and meta-analysis.
    Wu F; Lan Q; Yan L
    Am J Emerg Med; 2023 Sep; 71():109-116. PubMed ID: 37379618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The real-life value of ST2 monitoring during heart failure decompensation: impact on long-term readmission and mortality.
    Llibre C; Zamora E; Caballero À; Lupón J; Ros A; Benito N; de Antonio M; Galán A; Domingo M; Bayes-Genis A
    Biomarkers; 2016; 21(3):225-32. PubMed ID: 26767401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction.
    Friões F; Lourenço P; Laszczynska O; Almeida PB; Guimarães JT; Januzzi JL; Azevedo A; Bettencourt P
    Clin Res Cardiol; 2015 Jun; 104(6):491-9. PubMed ID: 25586507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure.
    Mueller T; Dieplinger B; Gegenhuber A; Poelz W; Pacher R; Haltmayer M
    Clin Chem; 2008 Apr; 54(4):752-6. PubMed ID: 18375488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis.
    Guo G; Huang A; Huang X; Xu T; Yao L
    Dis Markers; 2021; 2021():8881393. PubMed ID: 33574967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration.
    Homsak E; Ekart R
    Clin Chim Acta; 2018 Feb; 477():105-112. PubMed ID: 29221927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-hospital worsening heart failure in patients admitted for acute heart failure.
    Carubelli V; Cotter G; Davison B; Gishe J; Senger S; Bonadei I; Gorga E; Lazzarini V; Lombardi C; Metra M
    Int J Cardiol; 2016 Dec; 225():353-361. PubMed ID: 27756041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure.
    Barutaut M; Fournier P; Peacock WF; Evaristi MF; Dambrin C; Caubère C; Koukoui F; Galinier M; Smih F; Rouet P
    Acta Cardiol; 2020 Dec; 75(8):739-747. PubMed ID: 31560863
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure: A Pilot Study.
    Bayés-Genís A; Barallat J; Pascual-Figal D; Nuñez J; Miñana G; Sánchez-Mas J; Galan A; Sanchis J; Zamora E; Pérez-Martínez MT; Lupón J
    JACC Heart Fail; 2015 Aug; 3(8):641-4. PubMed ID: 26251092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT.
    Skali H; Gerwien R; Meyer TE; Snider JV; Solomon SD; Stolen CM
    J Cardiovasc Transl Res; 2016 Dec; 9(5-6):421-428. PubMed ID: 27798759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of decreased peripheral congestion detected by Bioelectrical Impedance Vector Analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure.
    Santarelli S; Russo V; Lalle I; De Berardinis B; Vetrone F; Magrini L; Di Stasio E; Piccoli A; Codognotto M; Mion MM; Castello LM; Avanzi GC; Di Somma S;
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):339-347. PubMed ID: 27073131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era of mechanical reperfusion therapy.
    Mechtouff L; Paccalet A; Crola Da Silva C; Buisson M; Mewton N; Amaz C; Bonnefoy-Cudraz E; Leboube S; Cho TH; Nighoghossian N; Ovize M; Bochaton T
    J Neurol; 2022 May; 269(5):2641-2648. PubMed ID: 34694426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Soluble Suppression of Tumorigenicity 2 Level Predicts All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis Patients: A Prospective Cohort Study.
    Zhang Z; Shen B; Cao X; Liu Z; Chen X; Nie Y; Yu J; Zou J; Ding X
    Blood Purif; 2017; 43(1-3):37-45. PubMed ID: 27875808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Significance of Discharge Hyponatremia in Heart Failure Patients With Normal Admission Sodium (from the ESCAPE Trial).
    Omar HR; Charnigo R; Guglin M
    Am J Cardiol; 2017 Aug; 120(4):607-615. PubMed ID: 28669488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.